Next Article in Journal
Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus
Next Article in Special Issue
Vaccination with Tozimameran Induces T-Cell Activation, but Not Senescent or Exhaustive Alterations, in Kidney Transplant Recipients
Previous Article in Journal
Immunogenicity and Protective Efficacy of Aerosolized Live-Attenuated Yellow Fever 17D Vaccine in Mice
Previous Article in Special Issue
Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting
 
 
Review

Article Versions Notes

Vaccines 2024, 12(8), 857; https://doi.org/10.3390/vaccines12080857
Action Date Notes Link
article xml file uploaded 30 July 2024 14:26 CEST Original file -
article xml uploaded. 30 July 2024 14:26 CEST Update https://www.mdpi.com/2076-393X/12/8/857/xml
article pdf uploaded. 30 July 2024 14:26 CEST Version of Record https://www.mdpi.com/2076-393X/12/8/857/pdf
article html file updated 30 July 2024 14:28 CEST Original file https://www.mdpi.com/2076-393X/12/8/857/html
Back to TopTop